Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, infections, oncology, and other diseases. It provides non-prescription products for oral cavity and pharynx; cough and cold; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others. In addition, the company offers animal health products comprising analgesics antimicrobials, antiparasitics, disinfectants, vitamins, and minerals. Further, the company provides health resort and tourist services. The company was founded in 1954 and is based in Novo Mesto, Slovenia.
Metrics to compare | KRKG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKRKGPeersSector | |
---|---|---|---|---|
P/E Ratio | 14.9x | −0.4x | −0.5x | |
PEG Ratio | 1.04 | 0.01 | 0.00 | |
Price/Book | 2.4x | 1.0x | 2.6x | |
Price / LTM Sales | 2.8x | 1.6x | 2.9x | |
Upside (Analyst Target) | 2.6% | 113.0% | 58.9% | |
Fair Value Upside | Unlock | 8.0% | 8.0% | Unlock |